Immunohistochemical expression of CYP11A1, CYP11B, CYP17, and HSD3B2 in functional and nonfunctional canine adrenocortical tumors

  • 0Department of Veterinary Clinical Sciences, Royal Veterinary College, University of London, Hertfordshire, United Kingdom.

|

|

Summary

This summary is machine-generated.

Immunohistochemistry for steroidogenic enzymes cannot determine canine adrenal tumor functionality. Tumor size also does not indicate adrenal tumor function in dogs.

Area Of Science

  • Veterinary Pathology
  • Endocrinology
  • Oncology

Background

  • Adrenal tumor functionality in humans is inferred by specific enzyme expression.
  • Canine adrenal tumors exhibit varied expression patterns based on functionality.

Purpose Of The Study

  • To investigate the utility of immunohistochemistry for steroidogenic enzymes in determining canine adrenal tumor functionality.
  • To correlate enzyme expression with tumor type (nonfunctional, cortisol-producing, aldosterone-producing).

Main Methods

  • Retrospective case series of 22 canine adrenocortical tumors (ACT) and 2 normal adrenal glands.
  • Immunohistochemistry used to detect CYP11A1, CYP11B, CYP17, and HSD3B2 expression.
  • Protein expression semiquantified and compared between nonfunctional and cortisol-producing ACT.

Main Results

  • No significant differences in CYP11A1, CYP11B, CYP17, or HSD3B2 expression were found between cortisol-producing and nonfunctional canine ACT.
  • Steroidogenic enzyme expression patterns did not reliably distinguish between functional and nonfunctional tumors.
  • Normal adrenal glands showed expression of CYP11A1, CYP11B, HSD3B2 in all layers, and CYP17 in specific layers.

Conclusions

  • Immunohistochemistry for steroidogenic enzymes is not a reliable method for determining canine adrenal tumor functionality.
  • Tumor size is also not a predictive factor for adrenal tumor functionality in dogs.